Search for: "AVENTIS PHARMACEUTICALS, INC.,"
Results 61 - 80
of 219
Sorted by Relevance
|
Sort by Date
27 May 2013, 7:22 pm
See Pharmaceuticals v. [read post]
10 May 2011, 4:24 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
20 Sep 2007, 10:05 pm
Lupin, Ltd. and Lupin Pharmaceuticals, Inc., No. 07, Civ. 0632 (D. [read post]
12 Sep 2007, 4:59 am
Forest Labs., Inc. v. [read post]
3 Apr 2019, 5:15 am
Amphastar Pharmaceutical, Inc., 525 F.3d 1334, 1349 (Fed.Cir.2008). [read post]
1 Jul 2010, 1:32 pm
Novartis Pfizer Sanofi-Aventis Takeda Pharmaceuticals [read post]
General disclosure in prior art not enabling for specific pharmaceutical compound's use in treatment
7 Oct 2008, 12:31 pm
Aventis Pharms Inc., after the jump. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
20 May 2013, 11:52 pm
” See Aventis Pharms., Inc. v. [read post]
5 Oct 2020, 10:25 am
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
15 Jun 2023, 2:20 pm
See, e.g., Sanofi-Aventis Deutschland GmbH v. [read post]
8 Jul 2011, 11:04 am
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
21 May 2010, 2:32 am
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
13 Nov 2007, 7:19 pm
The government's settlements with Bristol-Myers Squibb Co., Aventis Pharmaceuticals, Inc., Medco Health Solutions, Inc., Purdue Pharma L.P., Purdue Frederick Co., and InterMune, Inc. totalled over $800 million. [read post]
17 Mar 2022, 2:32 pm
Mylan Pharmaceuticals Inc. [read post]
23 Jul 2010, 10:55 am
Karst – Earlier today, FDA issued its long-awaited response (45 pages) to a February 2003 citizen petition submitted to the Agency on behalf of Aventis Pharmaceuticals, Inc. [read post]
